#dopamine — Public Fediverse posts

What did dopamine do to deserve this?

https://open.substack.com/pub/cognitivewonderland/p/what-did-dopamine-do-to-deserve-this?utm_campaign=post-expanded-share&utm_medium=web

A guest post by Dean Burnett for 'Cognitive Wonderland', which explores the surreal demonization in the modern discourse of the vital neurotransmitter dopamine

#Dopamine #Pleasure #Science #Brains

https://www.europesays.com/ie/483560/ AI-based generative framework create all-atom models of proteins in motion #Antibody #AntibodyDiscovery #ArtificialIntelligence #Cell #CellMembrane #Dopamine #Drugs #Éire #IE #Ireland #Laboratory #Membrane #Protein #Science

AI-based generative framework create all-atom models of proteins in motion https://www.byteseu.com/2017852/ #AI #Antibody #AntibodyDiscovery #ArtificialIntelligence #Cell #CellMembrane #dopamine #Drugs #Laboratory #Membrane #Protein

GLP-1 drugs may reshape how brain values rewarding foods

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does…
#NewsBeep #News #Medication #addiction #Amygdala #appetite #AU #Australia #Brain #Dopamine #Drugs #food #Health #Nausea #Neurons #oral #research #WeightLoss
https://www.newsbeep.com/au/666041/

GLP-1 drugs may reshape how brain values rewarding foods

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does…
#NewsBeep #News #Medication #addiction #Amygdala #appetite #AU #Australia #Brain #Dopamine #Drugs #food #Health #Nausea #Neurons #oral #research #WeightLoss
https://www.newsbeep.com/au/666041/

GLP-1 drugs may reshape how brain values rewarding foods

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does…
#NewsBeep #News #Medication #addiction #Amygdala #appetite #AU #Australia #Brain #Dopamine #Drugs #food #Health #Nausea #Neurons #oral #research #WeightLoss
https://www.newsbeep.com/au/666041/

GLP-1 drugs may reshape how brain values rewarding foods

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does…
#NewsBeep #News #Medication #addiction #Amygdala #appetite #AU #Australia #Brain #Dopamine #Drugs #food #Health #Nausea #Neurons #oral #research #WeightLoss
https://www.newsbeep.com/au/666041/

→ Talking to 35 Strangers at the Gym (by @thienantran)
https://thienantran.com/talking-to-35-strangers-at-the-gym/

“I had been conditioned to believe that initiating a conversation with a stranger was weird and it was tough to break free from that.”

“Luckily, most people were receptive. I got a rush of dopamine whenever someone responded positively to my conversation, so talking to new people became strangely addictive.”

#weird #people #talking #stranger #dopamine #conversation

L’esperta di dopamina, la Dott.ssa Anna Lembke, illustra come la dipendenza stia sequestrando intere vite.
La dipendenza dalla dopamina sta crescendo rapidamente: i pericoli dei social media, della pornografia, dell’IA, dei farmaci GLP-1...

#neurosciences #dipendenze #dopamine #brain #socualmedia #sociologia #psicologia
https://www.youtube.com/watch?v=2ZKLaUbB33o

The fascinating science of pleasure goes way beyond dopamine

https://psyche.co/ideas/the-fascinating-science-of-pleasure-goes-way-beyond-dopamine

Dean Burnett writes for Psyche Magazine about a particular bugbear of his; the mainstream misunderstanding of dopamine and its link to pleasure

#Dopamine #Addiction #Brains #Misinformation

"Now versus not now" thinking is natural.

Human brains crave immediate rewards over delayed outcomes. Bring the future payoff into the present moment. Give yourself a quick win just to start.

#TaskInitiation #Dopamine #ADHDMotivation

"Now versus not now" thinking is natural.

Human brains crave immediate rewards over delayed outcomes. Bring the future payoff into the present moment. Give yourself a quick win just to start.

#TaskInitiation #Dopamine #ADHDMotivation

We’ve been taught to call it love, but what if it’s just another high? From “you don’t get me high anymore” to “I don’t know how to live without this,” the language hasn’t changed but the substance has. If you need someone to function, that’s not romance.
#Music #Pop #Songlyrics #DemiLovato #Phantogram #Psychology #Addiction #Dopamine #MentalHealth #Codependency #Neuroscience #ToxicRelationships
https://pablohoneyfish.wordpress.com/2026/04/24/the-neurochemical-architecture-of-desensitization-phantograms-you-dont-get-me-high-anymore-and-demi-lovatos-wasted/

We’ve been taught to call it love, but what if it’s just another high? From “you don’t get me high anymore” to “I don’t know how to live without this,” the language hasn’t changed but the substance has. If you need someone to function, that’s not romance.
#Music #Pop #Songlyrics #DemiLovato #Phantogram #Psychology #Addiction #Dopamine #MentalHealth #Codependency #Neuroscience #ToxicRelationships
https://pablohoneyfish.wordpress.com/2026/04/24/the-neurochemical-architecture-of-desensitization-phantograms-you-dont-get-me-high-anymore-and-demi-lovatos-wasted/

We’ve been taught to call it love, but what if it’s just another high? From “you don’t get me high anymore” to “I don’t know how to live without this,” the language hasn’t changed but the substance has. If you need someone to function, that’s not romance.
#Music #Pop #Songlyrics #DemiLovato #Phantogram #Psychology #Addiction #Dopamine #MentalHealth #Codependency #Neuroscience #ToxicRelationships
https://pablohoneyfish.wordpress.com/2026/04/24/the-neurochemical-architecture-of-desensitization-phantograms-you-dont-get-me-high-anymore-and-demi-lovatos-wasted/

We’ve been taught to call it love, but what if it’s just another high? From “you don’t get me high anymore” to “I don’t know how to live without this,” the language hasn’t changed but the substance has. If you need someone to function, that’s not romance.
#Music #Pop #Songlyrics #DemiLovato #Phantogram #Psychology #Addiction #Dopamine #MentalHealth #Codependency #Neuroscience #ToxicRelationships
https://pablohoneyfish.wordpress.com/2026/04/24/the-neurochemical-architecture-of-desensitization-phantograms-you-dont-get-me-high-anymore-and-demi-lovatos-wasted/

We’ve been taught to call it love, but what if it’s just another high? From “you don’t get me high anymore” to “I don’t know how to live without this,” the language hasn’t changed but the substance has. If you need someone to function, that’s not romance.
#Music #Pop #Songlyrics #DemiLovato #Phantogram #Psychology #Addiction #Dopamine #MentalHealth #Codependency #Neuroscience #ToxicRelationships
https://pablohoneyfish.wordpress.com/2026/04/24/the-neurochemical-architecture-of-desensitization-phantograms-you-dont-get-me-high-anymore-and-demi-lovatos-wasted/

It had been sitting in a drawer for a few years, but I just revived it and set it free. I jailbroke my beloved iPhone SE (the original) in 2026, after jailbreaking my first iPhone 1 in 2008. Free your devices! You bought it, you own it.

#iphoneos #ios #jailbreak #trollstore #iphone #dopamine #sileo #zebra

Why Relationships Lose Spark? 🧠💔 | The Dopamine Routine
.
It’s not a loss of love; it’s a loss of stimulation. 🧬 In this episode of The Human Lab, we explore how the brain gets bored with routine and how "Novelty" can restart the Dopamine cycle. Discover the biological secret to keeping desire alive for years. 🧪💀

#TheHumanLab #Neuroscience #RelationshipAdvice #Dopamine #BrainFacts #Biology #ScienceShorts #LongTermLove

Why Men Lose Interest After Finishing? 🧠📉 | The Prolactin SecretIt’s not emotional coldness—it’s pure biology. 🧬 In this episode of The Human Lab, we explore the "Prolactin Spike" and "Dopamine Crash" that happens in the male brain after intimacy. Discover why the brain switches to recovery mode and how it differs for women. 🧪💀#TheHumanLab #Neuroscience #BiologyFacts #HormoneHealth #BrainScience #Dopamine #Prolactin #ScienceShorts

The Shocking Truth About Sugar & Energy 😮⁣
⁣
⁣
⁣
⁣
⁣
#sugar #energy #dopamine #healthtips #nutrition #mitochondria #sugarfacts #wellness #healthychoices #sciencefacts #healthyliving #foodscience #shorts #shortsvideo ⁣

You Cannot Build Depth While Chasing Shallow Rewards
https://wp.me/p84YjG-aIe
#dopamine #socialmediaaddiction #modernrelationships #datingtoday #trustissues #emotionalconnection #relationshipadvice #validation #selfgrowth #loveandtruth #mindsetshift #realrelationships #healingjourney #zsoltZsemba

https://zsoltzsemba.com/dopamine-attention-social-media-love-dating/

Dopamine Is Not Love
https://wp.me/p84YjG-aI3
#dopamine #socialmediaaddiction #modernrelationships #datingtoday #trustissues #emotionalconnection #relationshipadvice #validation #selfgrowth #loveandtruth #mindsetshift #realrelationships #healingjourney #zsoltzsemba

https://zsoltzsemba.com/dopamine-love-social-media-online-relationships/

https://www.evshift.com/432084/choose-yours-in-the-comments-%f0%9f%9a%97-vs-%e2%98%80%ef%b8%8f-dopamine-minicommunity-youtubeshorts/ Choose yours in the comments. 🚗 vs. ☀️
#Dopamine #MINICommunity #YoutubeShorts ##comments #CarHumour #choose #Dopamine #ElectricCars #ElectricVehicles #EV #mini #MiniCooper #MiniCooperSpecialEdition #MiniGpEdition #MINICommunity #RelatableCarHumour #SpecialEditionCar #youtubeshorts

Neuroscience explains why teens are so vulnerable to Big Tech social media platforms
#SocialMedia #Neuroscience #MentalHealth #Teen #BigTech #DigitalAddiction #Dopamine #Youth #Depression #Anxiety #Psychology #TechRegulation #OnlineHarms #MediaCriticism
https://the-14.com/neuroscience-explains-why-teens-are-so-vulnerable-to-big-tech-social-media-platforms/

“The relevance of a simple mathematical model breaks down when applied to the human brain, she says. “I don’t think these models are bad,” she says. “They become problematic when people get set in a model that’s been made to explain a very nuanced piece of data, and use it to explain the brain.””

https://www.nature.com/articles/d41586-026-00836-x

#neuroscience #dopamine #computational #ComputationalNeuroscience #modeling #data #brain

#Covidlong : inflammation chronique via ARN viral au niveau du tronc cérébral jusqu'à 3 mois après la phase aiguë de l'infection https://mastodon.social/@cobrate/116279848780997073

-> modification de l'expression des gènes liés au métabolisme du neurotransmetteur #dopamine

Symptômes :
- fatigue profonde
- troubles neurologiques #cerveau -> brouillard cérébral + enjeux mémoire
...

#covid19 #science #sante #politique #economie #sars #sarscov2 #handicap #covid #sang #comprendre #information

rained out today, de escalating family echo chamber and moving to independent counsel or at least some initial consults with paralegal to determine what, who, and where, if it merits contingency. retention is my whole game now and just have to execute and get a lot of letters in the mail, see what happens, i have not signed shit so that helps my cause, potentially #don't take it the wrong way shit #under the ai god #dopamine deserts

https://www.europesays.com/uk/783946/ Mounjaro’s Active Ingredient Slashes Alcohol Intake #addiction #AlcoholUseDisorder #AUD #Dopamine #Health #LateralSeptum #Medication #Mounjaro #neurobiology #neuropharmacology #Neuroscience #Tirzepatide #UK #UnitedKingdom #UniversityOfGothenburg

L'homme face au numérique

#humanite #revolution #numerique #reseauxsociaux #like #notification #piege #memoire #imagination #dopamine #ecran #magie #victime #complice #totalitaire #arme #liberte #sacre #animal #education #christianisme #priere #algorithme #artege #baptistedetombe

https://youtube.com/shorts/uV9NKh3ODTQ?feature=share

Losing interest

https://cynnisblog.wordpress.com/2026/01/28/losing-interest/

So... I measured the intensity of my shop lights. About 1000 watts per square meter at the light, which is the strength of sunlight during summer. The #UV index was a bit high at 8, compared to about 5 on a summer day. I doubt it's the same spectral UV distribution as sunlight and likely mostly UV-A, not UV-B required for vitamin-D production. At the bench, the visible light is a more reasonable 70 watts per meter and UV index is only 1. I probably should protect myself from the ionizing short rays as they do stress the living cells on my body.

But on the bright side, these lights may have completely cured my #nearsightedness, which was nearly disabling a year ago. From what I understand, bright light helps activate #dopamine which is required for the eye to communicate with itself and do eye things. I have no problems focusing when it's this bright in here! A year ago, it was dark in here and my blood tests showed high #prolactin, which is the opposing hormone of dopamine. I might test it again as good light seems to help.

The lights are powered from the 48 volt solar batteries through a current limiting DC-DC buck boost converter, which is rated for 40 amperes, but set at 8 amps, for about 350 watts. The light strip were from surplus industrial lighting. From what I understand, LED light output is typically much more efficient when a power supply pulses them at high currents, but this filtered DC is fine. I'll have to check the data sheets to see if that's still true like it was decades ago.

#lighting

[#veille] Comment TikTok et les Reels abîment notre cerveau ?
https://synthmedia.fr/ethique/comment-tiktok-et-les-reels-abiment-notre-cerveau/

#attention #neurologie #reseauxsociaux #scrolling #tiktok #instareels #dopamine

@AAKL

"This report, in contrast, is the opposite: It shows you 'account growth' and top x% Mastodon user' stats that I feel are detrimental to the reason people came to Mastodon.""

Necessary edit:

"This report ... shows you 'those #DopamineHit' stats that I feel are detrimental to the reason people came to Mastodon.""

I thought Mastodon was always about detoxing from #Dopamine

Apparently #Gargron et al want to join the Kool Kidz Klub and have #Mastodon be just like #YouTube and #Instagram and #Twitter and #Twitch and all the rest of the #Influencer hangouts

Here's me, 2025 from Twitch.

Whoopee!

Aren't I too cool for school?

#Wrapstodon2025 #Wrapstodon

From 619 Drugs to 1: Researchers Uncover Hidden Risk

Introduction: Addiction Risk in Commonly Prescribed Drugs

When you think of medication side effects, your mind probably goes to the warnings listed in commercials. Drowsiness, nausea, dizziness, etc. These are common, often manageable, and generally expected side effects of drugs.

But what about far more profound ones that can alter your behavior, strain your relationships, and impact your life?

A recent study delved into this very issue, analyzing VigiBase®, the World Health Organization’s global pharmacovigilance database, containing over 36 million adverse event reports, to uncover surprising links between everyday medications and the development of behavioral addictions.

The research sought to identify drugs where these life-altering risks are not officially listed, leaving us in the dark. This post will break down the most impactful findings from that detective work.

Takeaway 1: It’s Not Just the Usual Suspects Anymore

For years, the primary link between medication and behavioral addiction centered on a specific class of drugs: dopaminergic antagonists used to treat Parkinson’s disease.

The connection was so well-established that it was considered the main, and for many, the only, example of this phenomenon. This new study dramatically broadens that scope.

By analyzing reports from healthcare professionals worldwide, researchers identified seven classes of drugs associated with behavioral addictions, even though this risk is not officially listed as a side effect for them. These include: 

• Antidepressants 
• Antipsychotics (specifically, dopamine antagonists) 
• Antiepileptics 
• Benzodiazepines or related drugs 
• Psychostimulants 
• Retinoids 
• One antidiabetic drug

This finding is significant because it suggests the problem is far more widespread than previously understood. It potentially affects patients being treated for a wide range of common conditions.

Are you a professional looking to stay up-to-date with the latest information on, sex addiction, trauma, and mental health news and research? Or maybe you’re looking for continuing education courses?

Stay up-to-date with all of Dr. Jen’s work through her practice’s newsletter!

Takeaway 2: A Widely Used Antipsychotic Emerged as a Primary Concern

From an initial pool of 619 suspect medications reported at least five times, researchers applied a rigorous filtering process to hunt for the strongest signals. Ultimately, only one drug, Olanzapine, met all of the study’s highest evidence-based criteria. 

Olanzapine is a second-generation antipsychotic medication.

The study found that it had the most well-documented cases with strong evidence linking it to behavioral addiction. This evidence included reports where symptoms resolved after:

• The patient stopped taking the drug (a “positive dechallenge”)
• A significant statistical signal in the data
• Support from existing scientific publications

The study’s authors emphasized how their multi-step analysis narrowed the field to this single, compelling candidate: 

Our analysis allows to narrow down the search to include only the most thoroughly documented cases… This process culminated in reducing the initial count of 619 suspect to 1: Olanzapine. 

While Olanzapine was the only drug to meet every one of the study’s strictest criteria, the researchers noted that other antipsychotics also showed significant warning signs in the data. The specific behavioral addictions most strongly linked to Olanzapine included a range of behaviors such as binge eating, compulsive sexual behavior, compulsive shopping, and gambling disorder.

Takeaway 3: This Hidden Danger Isn’t Listed on the Drugs Official Label

The core purpose of the study was to identify drugs for which behavioral addiction is not listed as a known side effect in the official Summaries of Product Characteristics (SPCs). These are the detailed documents that guide doctors on a drug’s use and risks. 

The implication of this is critical: patients and even some doctors may be completely unaware of these potential risks when prescribing or taking these medications.

An individual experiencing a sudden onset of compulsive behavior might not connect it to their prescription, leading to confusion, distress, and delayed intervention. This research underscores the importance of “pharmacovigilance,” the ongoing science of monitoring drug safety after a medication is on the market.

It is a crucial tool for uncovering hidden patterns and rare side effects that may not have appeared in initial clinical trials.

Do you have enough hours for your LPC renewal? Are you in need of continuing education, but bored with the current offerings? Check out Dr. Weeks’ course on Cannabis Use Disorder, and other unique courses on her practice website.

Sexual Addiction Treatment Services has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7250. Programs that do not qualify for NBCC credit are clearly identified. Sexual Addiction Treatment Services is solely responsible for all aspects of the programs.

Takeaway 4: The Brain Science is More Complex Than Just Dopamine

Addiction is often explained through the lens of the brain’s reward system, which is heavily driven by the neurotransmitter dopamine.

This is why dopaminergic drugs for Parkinson’s were the first to be linked to behavioral addictions. However, the study’s findings on drugs like Olanzapine suggest a counter-intuitive possibility: the mechanism might involve a different system entirely.

Researchers theorize that for some of these medications, the effect may be caused by their interaction with the serotonergic system. Specifically, the way these drugs block certain serotonin receptors (known as 5HT2A receptors) could be responsible for inducing compulsive behaviors. 

This finding deepens our scientific understanding of addiction. It demonstrates that the pathways to addictive behavior in the brain are incredibly complex and varied, and not solely reliant on the dopamine system that has long dominated the conversation.

Conclusion: A Call for Greater Awareness of Drugs Side Effects

This research serves as a powerful reminder that our understanding of medication side effects is constantly evolving. What is considered safe today may reveal hidden complexities tomorrow. Ongoing research and diligent reporting by healthcare professionals are essential tools for ensuring patient safety long after a drug has been approved. 

The study’s findings highlight a potential blind spot in patient care. Life-altering behavioral changes might be mistakenly attributed to personal failings rather than a medication’s side effect.

This leads to a vital question for all of us: Knowing that these risks can go unlisted, how can we foster better conversations between patients and doctors about unexpected changes in behavior? 

Do you feel your sexual behavior, or that of someone you love, is out of control? Consult with a professional.

Are you exploring your trauma? Do you feel your childhood experiences were detrimental to your current mental or physical health? Utilize this free, validated, self-report questionnaire to find out.

Take the Adverse Childhood Experience (ACE) Questionnaire

Are you looking for more reputable data-backed information on sexual addiction? The Mitigation Aide Research Archive is an excellent source for executive summaries of research studies.

#addiction #addictiveBehaviors #antidepressants #antidiabetics #antiepileptics #antipsychotics #benzodiasepines #dopamine #dopaminergicAntagonists #drugAddiction #drugUse #drugs #hiddenDangersInMedications #highRiskMedications #olanzapine #prescriptionDrugs #psychostimulants #retinoids #who #worldHealthOrganization

From 619 Drugs to 1: Researchers Uncover Hidden Risk

Introduction: Addiction Risk in Commonly Prescribed Drugs

When you think of medication side effects, your mind probably goes to the warnings listed in commercials. Drowsiness, nausea, dizziness, etc. These are common, often manageable, and generally expected side effects of drugs.

But what about far more profound ones that can alter your behavior, strain your relationships, and impact your life?

A recent study delved into this very issue, analyzing VigiBase®, the World Health Organization’s global pharmacovigilance database, containing over 36 million adverse event reports, to uncover surprising links between everyday medications and the development of behavioral addictions.

The research sought to identify drugs where these life-altering risks are not officially listed, leaving us in the dark. This post will break down the most impactful findings from that detective work.

Takeaway 1: It’s Not Just the Usual Suspects Anymore

For years, the primary link between medication and behavioral addiction centered on a specific class of drugs: dopaminergic antagonists used to treat Parkinson’s disease.

The connection was so well-established that it was considered the main, and for many, the only, example of this phenomenon. This new study dramatically broadens that scope.

By analyzing reports from healthcare professionals worldwide, researchers identified seven classes of drugs associated with behavioral addictions, even though this risk is not officially listed as a side effect for them. These include: 

• Antidepressants 
• Antipsychotics (specifically, dopamine antagonists) 
• Antiepileptics 
• Benzodiazepines or related drugs 
• Psychostimulants 
• Retinoids 
• One antidiabetic drug

This finding is significant because it suggests the problem is far more widespread than previously understood. It potentially affects patients being treated for a wide range of common conditions.

Are you a professional looking to stay up-to-date with the latest information on, sex addiction, trauma, and mental health news and research? Or maybe you’re looking for continuing education courses?

Stay up-to-date with all of Dr. Jen’s work through her practice’s newsletter!

Takeaway 2: A Widely Used Antipsychotic Emerged as a Primary Concern

From an initial pool of 619 suspect medications reported at least five times, researchers applied a rigorous filtering process to hunt for the strongest signals. Ultimately, only one drug, Olanzapine, met all of the study’s highest evidence-based criteria. 

Olanzapine is a second-generation antipsychotic medication.

The study found that it had the most well-documented cases with strong evidence linking it to behavioral addiction. This evidence included reports where symptoms resolved after:

• The patient stopped taking the drug (a “positive dechallenge”)
• A significant statistical signal in the data
• Support from existing scientific publications

The study’s authors emphasized how their multi-step analysis narrowed the field to this single, compelling candidate: 

Our analysis allows to narrow down the search to include only the most thoroughly documented cases… This process culminated in reducing the initial count of 619 suspect to 1: Olanzapine. 

While Olanzapine was the only drug to meet every one of the study’s strictest criteria, the researchers noted that other antipsychotics also showed significant warning signs in the data. The specific behavioral addictions most strongly linked to Olanzapine included a range of behaviors such as binge eating, compulsive sexual behavior, compulsive shopping, and gambling disorder.

Takeaway 3: This Hidden Danger Isn’t Listed on the Drugs Official Label

The core purpose of the study was to identify drugs for which behavioral addiction is not listed as a known side effect in the official Summaries of Product Characteristics (SPCs). These are the detailed documents that guide doctors on a drug’s use and risks. 

The implication of this is critical: patients and even some doctors may be completely unaware of these potential risks when prescribing or taking these medications.

An individual experiencing a sudden onset of compulsive behavior might not connect it to their prescription, leading to confusion, distress, and delayed intervention. This research underscores the importance of “pharmacovigilance,” the ongoing science of monitoring drug safety after a medication is on the market.

It is a crucial tool for uncovering hidden patterns and rare side effects that may not have appeared in initial clinical trials.

Do you have enough hours for your LPC renewal? Are you in need of continuing education, but bored with the current offerings? Check out Dr. Weeks’ course on Cannabis Use Disorder, and other unique courses on her practice website.

Sexual Addiction Treatment Services has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7250. Programs that do not qualify for NBCC credit are clearly identified. Sexual Addiction Treatment Services is solely responsible for all aspects of the programs.

Takeaway 4: The Brain Science is More Complex Than Just Dopamine

Addiction is often explained through the lens of the brain’s reward system, which is heavily driven by the neurotransmitter dopamine.

This is why dopaminergic drugs for Parkinson’s were the first to be linked to behavioral addictions. However, the study’s findings on drugs like Olanzapine suggest a counter-intuitive possibility: the mechanism might involve a different system entirely.

Researchers theorize that for some of these medications, the effect may be caused by their interaction with the serotonergic system. Specifically, the way these drugs block certain serotonin receptors (known as 5HT2A receptors) could be responsible for inducing compulsive behaviors. 

This finding deepens our scientific understanding of addiction. It demonstrates that the pathways to addictive behavior in the brain are incredibly complex and varied, and not solely reliant on the dopamine system that has long dominated the conversation.

Conclusion: A Call for Greater Awareness of Drugs Side Effects

This research serves as a powerful reminder that our understanding of medication side effects is constantly evolving. What is considered safe today may reveal hidden complexities tomorrow. Ongoing research and diligent reporting by healthcare professionals are essential tools for ensuring patient safety long after a drug has been approved. 

The study’s findings highlight a potential blind spot in patient care. Life-altering behavioral changes might be mistakenly attributed to personal failings rather than a medication’s side effect.

This leads to a vital question for all of us: Knowing that these risks can go unlisted, how can we foster better conversations between patients and doctors about unexpected changes in behavior? 

Do you feel your sexual behavior, or that of someone you love, is out of control? Consult with a professional.

Are you exploring your trauma? Do you feel your childhood experiences were detrimental to your current mental or physical health? Utilize this free, validated, self-report questionnaire to find out.

Take the Adverse Childhood Experience (ACE) Questionnaire

Are you looking for more reputable data-backed information on sexual addiction? The Mitigation Aide Research Archive is an excellent source for executive summaries of research studies.

#addiction #addictiveBehaviors #antidepressants #antidiabetics #antiepileptics #antipsychotics #benzodiasepines #dopamine #dopaminergicAntagonists #drugAddiction #drugUse #drugs #hiddenDangersInMedications #highRiskMedications #olanzapine #prescriptionDrugs #psychostimulants #retinoids #who #worldHealthOrganization

From 619 Drugs to 1: Researchers Uncover Hidden Risk

Introduction: Addiction Risk in Commonly Prescribed Drugs

When you think of medication side effects, your mind probably goes to the warnings listed in commercials. Drowsiness, nausea, dizziness, etc. These are common, often manageable, and generally expected side effects of drugs.

But what about far more profound ones that can alter your behavior, strain your relationships, and impact your life?

A recent study delved into this very issue, analyzing VigiBase®, the World Health Organization’s global pharmacovigilance database, containing over 36 million adverse event reports, to uncover surprising links between everyday medications and the development of behavioral addictions.

The research sought to identify drugs where these life-altering risks are not officially listed, leaving us in the dark. This post will break down the most impactful findings from that detective work.

Takeaway 1: It’s Not Just the Usual Suspects Anymore

For years, the primary link between medication and behavioral addiction centered on a specific class of drugs: dopaminergic antagonists used to treat Parkinson’s disease.

The connection was so well-established that it was considered the main, and for many, the only, example of this phenomenon. This new study dramatically broadens that scope.

By analyzing reports from healthcare professionals worldwide, researchers identified seven classes of drugs associated with behavioral addictions, even though this risk is not officially listed as a side effect for them. These include: 

• Antidepressants 
• Antipsychotics (specifically, dopamine antagonists) 
• Antiepileptics 
• Benzodiazepines or related drugs 
• Psychostimulants 
• Retinoids 
• One antidiabetic drug

This finding is significant because it suggests the problem is far more widespread than previously understood. It potentially affects patients being treated for a wide range of common conditions.

Are you a professional looking to stay up-to-date with the latest information on, sex addiction, trauma, and mental health news and research? Or maybe you’re looking for continuing education courses?

Stay up-to-date with all of Dr. Jen’s work through her practice’s newsletter!

Takeaway 2: A Widely Used Antipsychotic Emerged as a Primary Concern

From an initial pool of 619 suspect medications reported at least five times, researchers applied a rigorous filtering process to hunt for the strongest signals. Ultimately, only one drug, Olanzapine, met all of the study’s highest evidence-based criteria. 

Olanzapine is a second-generation antipsychotic medication.

The study found that it had the most well-documented cases with strong evidence linking it to behavioral addiction. This evidence included reports where symptoms resolved after:

• The patient stopped taking the drug (a “positive dechallenge”)
• A significant statistical signal in the data
• Support from existing scientific publications

The study’s authors emphasized how their multi-step analysis narrowed the field to this single, compelling candidate: 

Our analysis allows to narrow down the search to include only the most thoroughly documented cases… This process culminated in reducing the initial count of 619 suspect to 1: Olanzapine. 

While Olanzapine was the only drug to meet every one of the study’s strictest criteria, the researchers noted that other antipsychotics also showed significant warning signs in the data. The specific behavioral addictions most strongly linked to Olanzapine included a range of behaviors such as binge eating, compulsive sexual behavior, compulsive shopping, and gambling disorder.

Takeaway 3: This Hidden Danger Isn’t Listed on the Drugs Official Label

The core purpose of the study was to identify drugs for which behavioral addiction is not listed as a known side effect in the official Summaries of Product Characteristics (SPCs). These are the detailed documents that guide doctors on a drug’s use and risks. 

The implication of this is critical: patients and even some doctors may be completely unaware of these potential risks when prescribing or taking these medications.

An individual experiencing a sudden onset of compulsive behavior might not connect it to their prescription, leading to confusion, distress, and delayed intervention. This research underscores the importance of “pharmacovigilance,” the ongoing science of monitoring drug safety after a medication is on the market.

It is a crucial tool for uncovering hidden patterns and rare side effects that may not have appeared in initial clinical trials.

Do you have enough hours for your LPC renewal? Are you in need of continuing education, but bored with the current offerings? Check out Dr. Weeks’ course on Cannabis Use Disorder, and other unique courses on her practice website.

Sexual Addiction Treatment Services has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7250. Programs that do not qualify for NBCC credit are clearly identified. Sexual Addiction Treatment Services is solely responsible for all aspects of the programs.

Takeaway 4: The Brain Science is More Complex Than Just Dopamine

Addiction is often explained through the lens of the brain’s reward system, which is heavily driven by the neurotransmitter dopamine.

This is why dopaminergic drugs for Parkinson’s were the first to be linked to behavioral addictions. However, the study’s findings on drugs like Olanzapine suggest a counter-intuitive possibility: the mechanism might involve a different system entirely.

Researchers theorize that for some of these medications, the effect may be caused by their interaction with the serotonergic system. Specifically, the way these drugs block certain serotonin receptors (known as 5HT2A receptors) could be responsible for inducing compulsive behaviors. 

This finding deepens our scientific understanding of addiction. It demonstrates that the pathways to addictive behavior in the brain are incredibly complex and varied, and not solely reliant on the dopamine system that has long dominated the conversation.

Conclusion: A Call for Greater Awareness of Drugs Side Effects

This research serves as a powerful reminder that our understanding of medication side effects is constantly evolving. What is considered safe today may reveal hidden complexities tomorrow. Ongoing research and diligent reporting by healthcare professionals are essential tools for ensuring patient safety long after a drug has been approved. 

The study’s findings highlight a potential blind spot in patient care. Life-altering behavioral changes might be mistakenly attributed to personal failings rather than a medication’s side effect.

This leads to a vital question for all of us: Knowing that these risks can go unlisted, how can we foster better conversations between patients and doctors about unexpected changes in behavior? 

Do you feel your sexual behavior, or that of someone you love, is out of control? Consult with a professional.

Are you exploring your trauma? Do you feel your childhood experiences were detrimental to your current mental or physical health? Utilize this free, validated, self-report questionnaire to find out.

Take the Adverse Childhood Experience (ACE) Questionnaire

Are you looking for more reputable data-backed information on sexual addiction? The Mitigation Aide Research Archive is an excellent source for executive summaries of research studies.

#addiction #addictiveBehaviors #antidepressants #antidiabetics #antiepileptics #antipsychotics #benzodiasepines #dopamine #dopaminergicAntagonists #drugAddiction #drugUse #drugs #hiddenDangersInMedications #highRiskMedications #olanzapine #prescriptionDrugs #psychostimulants #retinoids #who #worldHealthOrganization

From 619 Drugs to 1: Researchers Uncover Hidden Risk

Introduction: Addiction Risk in Commonly Prescribed Drugs

When you think of medication side effects, your mind probably goes to the warnings listed in commercials. Drowsiness, nausea, dizziness, etc. These are common, often manageable, and generally expected side effects of drugs.

But what about far more profound ones that can alter your behavior, strain your relationships, and impact your life?

A recent study delved into this very issue, analyzing VigiBase®, the World Health Organization’s global pharmacovigilance database, containing over 36 million adverse event reports, to uncover surprising links between everyday medications and the development of behavioral addictions.

The research sought to identify drugs where these life-altering risks are not officially listed, leaving us in the dark. This post will break down the most impactful findings from that detective work.

Takeaway 1: It’s Not Just the Usual Suspects Anymore

For years, the primary link between medication and behavioral addiction centered on a specific class of drugs: dopaminergic antagonists used to treat Parkinson’s disease.

The connection was so well-established that it was considered the main, and for many, the only, example of this phenomenon. This new study dramatically broadens that scope.

By analyzing reports from healthcare professionals worldwide, researchers identified seven classes of drugs associated with behavioral addictions, even though this risk is not officially listed as a side effect for them. These include: 

• Antidepressants 
• Antipsychotics (specifically, dopamine antagonists) 
• Antiepileptics 
• Benzodiazepines or related drugs 
• Psychostimulants 
• Retinoids 
• One antidiabetic drug

This finding is significant because it suggests the problem is far more widespread than previously understood. It potentially affects patients being treated for a wide range of common conditions.

Are you a professional looking to stay up-to-date with the latest information on, sex addiction, trauma, and mental health news and research? Or maybe you’re looking for continuing education courses?

Stay up-to-date with all of Dr. Jen’s work through her practice’s newsletter!

Takeaway 2: A Widely Used Antipsychotic Emerged as a Primary Concern

From an initial pool of 619 suspect medications reported at least five times, researchers applied a rigorous filtering process to hunt for the strongest signals. Ultimately, only one drug, Olanzapine, met all of the study’s highest evidence-based criteria. 

Olanzapine is a second-generation antipsychotic medication.

The study found that it had the most well-documented cases with strong evidence linking it to behavioral addiction. This evidence included reports where symptoms resolved after:

• The patient stopped taking the drug (a “positive dechallenge”)
• A significant statistical signal in the data
• Support from existing scientific publications

The study’s authors emphasized how their multi-step analysis narrowed the field to this single, compelling candidate: 

Our analysis allows to narrow down the search to include only the most thoroughly documented cases… This process culminated in reducing the initial count of 619 suspect to 1: Olanzapine. 

While Olanzapine was the only drug to meet every one of the study’s strictest criteria, the researchers noted that other antipsychotics also showed significant warning signs in the data. The specific behavioral addictions most strongly linked to Olanzapine included a range of behaviors such as binge eating, compulsive sexual behavior, compulsive shopping, and gambling disorder.

Takeaway 3: This Hidden Danger Isn’t Listed on the Drugs Official Label

The core purpose of the study was to identify drugs for which behavioral addiction is not listed as a known side effect in the official Summaries of Product Characteristics (SPCs). These are the detailed documents that guide doctors on a drug’s use and risks. 

The implication of this is critical: patients and even some doctors may be completely unaware of these potential risks when prescribing or taking these medications.

An individual experiencing a sudden onset of compulsive behavior might not connect it to their prescription, leading to confusion, distress, and delayed intervention. This research underscores the importance of “pharmacovigilance,” the ongoing science of monitoring drug safety after a medication is on the market.

It is a crucial tool for uncovering hidden patterns and rare side effects that may not have appeared in initial clinical trials.

Do you have enough hours for your LPC renewal? Are you in need of continuing education, but bored with the current offerings? Check out Dr. Weeks’ course on Cannabis Use Disorder, and other unique courses on her practice website.

Sexual Addiction Treatment Services has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7250. Programs that do not qualify for NBCC credit are clearly identified. Sexual Addiction Treatment Services is solely responsible for all aspects of the programs.

Takeaway 4: The Brain Science is More Complex Than Just Dopamine

Addiction is often explained through the lens of the brain’s reward system, which is heavily driven by the neurotransmitter dopamine.

This is why dopaminergic drugs for Parkinson’s were the first to be linked to behavioral addictions. However, the study’s findings on drugs like Olanzapine suggest a counter-intuitive possibility: the mechanism might involve a different system entirely.

Researchers theorize that for some of these medications, the effect may be caused by their interaction with the serotonergic system. Specifically, the way these drugs block certain serotonin receptors (known as 5HT2A receptors) could be responsible for inducing compulsive behaviors. 

This finding deepens our scientific understanding of addiction. It demonstrates that the pathways to addictive behavior in the brain are incredibly complex and varied, and not solely reliant on the dopamine system that has long dominated the conversation.

Conclusion: A Call for Greater Awareness of Drugs Side Effects

This research serves as a powerful reminder that our understanding of medication side effects is constantly evolving. What is considered safe today may reveal hidden complexities tomorrow. Ongoing research and diligent reporting by healthcare professionals are essential tools for ensuring patient safety long after a drug has been approved. 

The study’s findings highlight a potential blind spot in patient care. Life-altering behavioral changes might be mistakenly attributed to personal failings rather than a medication’s side effect.

This leads to a vital question for all of us: Knowing that these risks can go unlisted, how can we foster better conversations between patients and doctors about unexpected changes in behavior? 

Do you feel your sexual behavior, or that of someone you love, is out of control? Consult with a professional.

Are you exploring your trauma? Do you feel your childhood experiences were detrimental to your current mental or physical health? Utilize this free, validated, self-report questionnaire to find out.

Take the Adverse Childhood Experience (ACE) Questionnaire

Are you looking for more reputable data-backed information on sexual addiction? The Mitigation Aide Research Archive is an excellent source for executive summaries of research studies.

#addiction #addictiveBehaviors #antidepressants #antidiabetics #antiepileptics #antipsychotics #benzodiasepines #dopamine #dopaminergicAntagonists #drugAddiction #drugUse #drugs #hiddenDangersInMedications #highRiskMedications #olanzapine #prescriptionDrugs #psychostimulants #retinoids #who #worldHealthOrganization

From 619 Drugs to 1: Researchers Uncover Hidden Risk

Introduction: Addiction Risk in Commonly Prescribed Drugs

When you think of medication side effects, your mind probably goes to the warnings listed in commercials. Drowsiness, nausea, dizziness, etc. These are common, often manageable, and generally expected side effects of drugs.

But what about far more profound ones that can alter your behavior, strain your relationships, and impact your life?

A recent study delved into this very issue, analyzing VigiBase®, the World Health Organization’s global pharmacovigilance database, containing over 36 million adverse event reports, to uncover surprising links between everyday medications and the development of behavioral addictions.

The research sought to identify drugs where these life-altering risks are not officially listed, leaving us in the dark. This post will break down the most impactful findings from that detective work.

Takeaway 1: It’s Not Just the Usual Suspects Anymore

For years, the primary link between medication and behavioral addiction centered on a specific class of drugs: dopaminergic antagonists used to treat Parkinson’s disease.

The connection was so well-established that it was considered the main, and for many, the only, example of this phenomenon. This new study dramatically broadens that scope.

By analyzing reports from healthcare professionals worldwide, researchers identified seven classes of drugs associated with behavioral addictions, even though this risk is not officially listed as a side effect for them. These include: 

• Antidepressants 
• Antipsychotics (specifically, dopamine antagonists) 
• Antiepileptics 
• Benzodiazepines or related drugs 
• Psychostimulants 
• Retinoids 
• One antidiabetic drug

This finding is significant because it suggests the problem is far more widespread than previously understood. It potentially affects patients being treated for a wide range of common conditions.

Are you a professional looking to stay up-to-date with the latest information on, sex addiction, trauma, and mental health news and research? Or maybe you’re looking for continuing education courses?

Stay up-to-date with all of Dr. Jen’s work through her practice’s newsletter!

Takeaway 2: A Widely Used Antipsychotic Emerged as a Primary Concern

From an initial pool of 619 suspect medications reported at least five times, researchers applied a rigorous filtering process to hunt for the strongest signals. Ultimately, only one drug, Olanzapine, met all of the study’s highest evidence-based criteria. 

Olanzapine is a second-generation antipsychotic medication.

The study found that it had the most well-documented cases with strong evidence linking it to behavioral addiction. This evidence included reports where symptoms resolved after:

• The patient stopped taking the drug (a “positive dechallenge”)
• A significant statistical signal in the data
• Support from existing scientific publications

The study’s authors emphasized how their multi-step analysis narrowed the field to this single, compelling candidate: 

Our analysis allows to narrow down the search to include only the most thoroughly documented cases… This process culminated in reducing the initial count of 619 suspect to 1: Olanzapine. 

While Olanzapine was the only drug to meet every one of the study’s strictest criteria, the researchers noted that other antipsychotics also showed significant warning signs in the data. The specific behavioral addictions most strongly linked to Olanzapine included a range of behaviors such as binge eating, compulsive sexual behavior, compulsive shopping, and gambling disorder.

Takeaway 3: This Hidden Danger Isn’t Listed on the Drugs Official Label

The core purpose of the study was to identify drugs for which behavioral addiction is not listed as a known side effect in the official Summaries of Product Characteristics (SPCs). These are the detailed documents that guide doctors on a drug’s use and risks. 

The implication of this is critical: patients and even some doctors may be completely unaware of these potential risks when prescribing or taking these medications.

An individual experiencing a sudden onset of compulsive behavior might not connect it to their prescription, leading to confusion, distress, and delayed intervention. This research underscores the importance of “pharmacovigilance,” the ongoing science of monitoring drug safety after a medication is on the market.

It is a crucial tool for uncovering hidden patterns and rare side effects that may not have appeared in initial clinical trials.

Do you have enough hours for your LPC renewal? Are you in need of continuing education, but bored with the current offerings? Check out Dr. Weeks’ course on Cannabis Use Disorder, and other unique courses on her practice website.

Sexual Addiction Treatment Services has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7250. Programs that do not qualify for NBCC credit are clearly identified. Sexual Addiction Treatment Services is solely responsible for all aspects of the programs.

Takeaway 4: The Brain Science is More Complex Than Just Dopamine

Addiction is often explained through the lens of the brain’s reward system, which is heavily driven by the neurotransmitter dopamine.

This is why dopaminergic drugs for Parkinson’s were the first to be linked to behavioral addictions. However, the study’s findings on drugs like Olanzapine suggest a counter-intuitive possibility: the mechanism might involve a different system entirely.

Researchers theorize that for some of these medications, the effect may be caused by their interaction with the serotonergic system. Specifically, the way these drugs block certain serotonin receptors (known as 5HT2A receptors) could be responsible for inducing compulsive behaviors. 

This finding deepens our scientific understanding of addiction. It demonstrates that the pathways to addictive behavior in the brain are incredibly complex and varied, and not solely reliant on the dopamine system that has long dominated the conversation.

Conclusion: A Call for Greater Awareness of Drugs Side Effects

This research serves as a powerful reminder that our understanding of medication side effects is constantly evolving. What is considered safe today may reveal hidden complexities tomorrow. Ongoing research and diligent reporting by healthcare professionals are essential tools for ensuring patient safety long after a drug has been approved. 

The study’s findings highlight a potential blind spot in patient care. Life-altering behavioral changes might be mistakenly attributed to personal failings rather than a medication’s side effect.

This leads to a vital question for all of us: Knowing that these risks can go unlisted, how can we foster better conversations between patients and doctors about unexpected changes in behavior? 

Do you feel your sexual behavior, or that of someone you love, is out of control? Consult with a professional.

Are you exploring your trauma? Do you feel your childhood experiences were detrimental to your current mental or physical health? Utilize this free, validated, self-report questionnaire to find out.

Take the Adverse Childhood Experience (ACE) Questionnaire

Are you looking for more reputable data-backed information on sexual addiction? The Mitigation Aide Research Archive is an excellent source for executive summaries of research studies.

#addiction #addictiveBehaviors #antidepressants #antidiabetics #antiepileptics #antipsychotics #benzodiasepines #dopamine #dopaminergicAntagonists #drugAddiction #drugUse #drugs #hiddenDangersInMedications #highRiskMedications #olanzapine #prescriptionDrugs #psychostimulants #retinoids #who #worldHealthOrganization

Not a cult.. Not a belief system... This is a guy who teaches you how to access your #brain #neurochemistry no matter what you believe. This is the pathway into the brain for anything. And it can change everything. #science #dopamine #brainwashing yourself for your own good is possible!

RE: https://bsky.app/profile/did:plc:i3ftm5bma56x5wnavtcmffa5/post/3m4ep6eiffc2u

Unlocking brain protection with hydroxytyrosol from olives https://www.diningandcooking.com/2355799/unlocking-brain-protection-with-hydroxytyrosol-from-olives/ ##inflammation #AntiInflammatory #antioxidant #blood #BRAIN #cancer #children #chronic #compound #Dopamine #Dopaminergic #Efficacy #food #FoodSafety #Mediterranean #MediterraneanOliveOil #Molecule #nutrition #Olive #OliveOil #OxidativeStress #Preclinical #stress #vascular

"The dopaminergic system of Caenorhabditis elegans", Muralidhara and Hardege, 2025
https://royalsocietypublishing.org/doi/10.1098/rsos.250843

That's the review I was waiting for – finally I have the field laid out to write the reinterpretation of part of the worm's pharyngeal ring – aka the brain – as an antennal lobe and a mushroom body.

#Celegans #neuroscience #dopamine

"The dopaminergic system of Caenorhabditis elegans", Muralidhara and Hardege, 2025
https://royalsocietypublishing.org/doi/10.1098/rsos.250843

That's the review I was waiting for – finally I have the field laid out to write the reinterpretation of part of the worm's pharyngeal ring – aka the brain – as an antennal lobe and a mushroom body.

#Celegans #neuroscience #dopamine

"The dopaminergic system of Caenorhabditis elegans", Muralidhara and Hardege, 2025
https://royalsocietypublishing.org/doi/10.1098/rsos.250843

That's the review I was waiting for – finally I have the field laid out to write the reinterpretation of part of the worm's pharyngeal ring – aka the brain – as an antennal lobe and a mushroom body.

#Celegans #neuroscience #dopamine

"The dopaminergic system of Caenorhabditis elegans", Muralidhara and Hardege, 2025
https://royalsocietypublishing.org/doi/10.1098/rsos.250843

That's the review I was waiting for – finally I have the field laid out to write the reinterpretation of part of the worm's pharyngeal ring – aka the brain – as an antennal lobe and a mushroom body.

#Celegans #neuroscience #dopamine

"The dopaminergic system of Caenorhabditis elegans", Muralidhara and Hardege, 2025
https://royalsocietypublishing.org/doi/10.1098/rsos.250843

That's the review I was waiting for – finally I have the field laid out to write the reinterpretation of part of the worm's pharyngeal ring – aka the brain – as an antennal lobe and a mushroom body.

#Celegans #neuroscience #dopamine

I understand that commercial companies pursue profits, but pushing short videos so aggressively – placing them front and center without even offering an option to hide them – is disappointing.
As a result, most people suffer: scattered attention, lack of motivation, and what experts call Short Video Addiction (SVA). This isn’t a joke – SVA is a rapidly growing, serious problem as companies like Meta, Google (YouTube Shorts), TikTok, and others profit more and more from this trend.

Recent research, such as a study in “Frontiers in Public Health” (https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1484117/full), has confirmed just how damaging SVA can be. The study found that SVA not only impairs cognitive function and diminishes attention span but can also cause persistent, even irreversible, problems with focus and self-regulation – especially among young people whose brains are still developing.
Algorithms on platforms like TikTok and Snapchat intentionally exploit these vulnerabilities, encourage compulsive viewing, and can fundamentally change how our brains process reward.

Personally, I would really like at least the option to hide short videos—or better yet, to get rid of them completely.

To creators: What motivates you to make so much short content? Do you see it as profitable, or what?

#ShortVideoAddiction #SVA #dopamine #attention #DigitalWellbeing #Fediverse #platformcritique #FediTalk

I understand that commercial companies pursue profits, but pushing short videos so aggressively – placing them front and center without even offering an option to hide them – is disappointing.
As a result, most people suffer: scattered attention, lack of motivation, and what experts call Short Video Addiction (SVA). This isn’t a joke – SVA is a rapidly growing, serious problem as companies like Meta, Google (YouTube Shorts), TikTok, and others profit more and more from this trend.

Recent research, such as a study in “Frontiers in Public Health” (https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1484117/full), has confirmed just how damaging SVA can be. The study found that SVA not only impairs cognitive function and diminishes attention span but can also cause persistent, even irreversible, problems with focus and self-regulation – especially among young people whose brains are still developing.
Algorithms on platforms like TikTok and Snapchat intentionally exploit these vulnerabilities, encourage compulsive viewing, and can fundamentally change how our brains process reward.

Personally, I would really like at least the option to hide short videos—or better yet, to get rid of them completely.

To creators: What motivates you to make so much short content? Do you see it as profitable, or what?

#ShortVideoAddiction #SVA #dopamine #attention #DigitalWellbeing #Fediverse #platformcritique #FediTalk

I understand that commercial companies pursue profits, but pushing short videos so aggressively – placing them front and center without even offering an option to hide them – is disappointing.
As a result, most people suffer: scattered attention, lack of motivation, and what experts call Short Video Addiction (SVA). This isn’t a joke – SVA is a rapidly growing, serious problem as companies like Meta, Google (YouTube Shorts), TikTok, and others profit more and more from this trend.

Recent research, such as a study in “Frontiers in Public Health” (https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1484117/full), has confirmed just how damaging SVA can be. The study found that SVA not only impairs cognitive function and diminishes attention span but can also cause persistent, even irreversible, problems with focus and self-regulation – especially among young people whose brains are still developing.
Algorithms on platforms like TikTok and Snapchat intentionally exploit these vulnerabilities, encourage compulsive viewing, and can fundamentally change how our brains process reward.

Personally, I would really like at least the option to hide short videos—or better yet, to get rid of them completely.

To creators: What motivates you to make so much short content? Do you see it as profitable, or what?

#ShortVideoAddiction #SVA #dopamine #attention #DigitalWellbeing #Fediverse #platformcritique #FediTalk

I understand that commercial companies pursue profits, but pushing short videos so aggressively – placing them front and center without even offering an option to hide them – is disappointing.
As a result, most people suffer: scattered attention, lack of motivation, and what experts call Short Video Addiction (SVA). This isn’t a joke – SVA is a rapidly growing, serious problem as companies like Meta, Google (YouTube Shorts), TikTok, and others profit more and more from this trend.

Recent research, such as a study in “Frontiers in Public Health” (https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2024.1484117/full), has confirmed just how damaging SVA can be. The study found that SVA not only impairs cognitive function and diminishes attention span but can also cause persistent, even irreversible, problems with focus and self-regulation – especially among young people whose brains are still developing.
Algorithms on platforms like TikTok and Snapchat intentionally exploit these vulnerabilities, encourage compulsive viewing, and can fundamentally change how our brains process reward.

Personally, I would really like at least the option to hide short videos—or better yet, to get rid of them completely.

To creators: What motivates you to make so much short content? Do you see it as profitable, or what?

#ShortVideoAddiction #SVA #dopamine #attention #DigitalWellbeing #Fediverse #platformcritique #FediTalk